First Time Loading...

Strides Pharma Science Ltd
NSE:STAR

Watchlist Manager
Strides Pharma Science Ltd Logo
Strides Pharma Science Ltd
NSE:STAR
Watchlist
Price: 978.7 INR 3.92% Market Closed
Updated: Jun 16, 2024
Have any thoughts about
Strides Pharma Science Ltd?
Write Note

Strides Pharma Science Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Strides Pharma Science Ltd
Operating Income Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Strides Pharma Science Ltd
NSE:STAR
Operating Income
â‚ą5.2B
CAGR 3-Years
6%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Operating Income
â‚ą64.6B
CAGR 3-Years
25%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Operating Income
â‚ą52.4B
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
12%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Operating Income
â‚ą104.3B
CAGR 3-Years
17%
CAGR 5-Years
16%
CAGR 10-Years
5%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Operating Income
â‚ą45.4B
CAGR 3-Years
18%
CAGR 5-Years
14%
CAGR 10-Years
16%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Operating Income
â‚ą25.6B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
11%

See Also

What is Strides Pharma Science Ltd's Operating Income?
Operating Income
5.2B INR

Based on the financial report for Mar 31, 2024, Strides Pharma Science Ltd's Operating Income amounts to 5.2B INR.

What is Strides Pharma Science Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
29%

Over the last year, the Operating Income growth was 261%. The average annual Operating Income growth rates for Strides Pharma Science Ltd have been 6% over the past three years , 29% over the past five years .